Laurion Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-16,954
Closed -$1.73M – 510
2023
Q3
$1.58M Buy
16,954
+9,839
+138% +$1.11M 0.01% 348
2023
Q2
$914K Buy
+7,115
New +$861K 0.01% 376
2022
Q2
– Sell
-3,852
Closed -$493K – 542
2022
Q1
$493K Buy
3,852
+1,452
+61% +$159K 0.01% 332
2021
Q4
$322K Buy
+2,400
New +$345K ﹤0.01% 457
2021
Q1
– Sell
-3,600
Closed -$333K – 783
2020
Q4
$333K Buy
+3,600
New +$321K ﹤0.01% 533
2020
Q3
– Sell
-26,584
Closed -$2.78M – 910
2020
Q2
$2.69M Buy
+26,584
New +$2.38M 0.03% 295
2017
Q2
– Sell
-17,600
Closed -$373K – 1678
2017
Q1
$373K Buy
+17,600
New +$344K ﹤0.01% 998
2016
Q1
– Sell
-13,600
Closed -$278K – 846
2015
Q4
$278K Buy
+13,600
New +$283K ﹤0.01% 736
2015
Q3
– Sell
-269,600
Closed -$5.39M – 771
2015
Q2
$5.39M Buy
+269,600
New +$4.74M 0.05% 286

Other funds holding DXCM

Laurion Capital Management's DXCM Position: Q4 2023 in Review

Laurion Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 16,954 shares — an estimated $1.73M sold.

Laurion Capital Management first reported a position in DXCM in Q2 2015 and held it in 9 quarters. The position peaked at $5.39M in Q2 2015. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Laurion Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Laurion Capital Management sold 16,954 DexCom shares in Q4 2023, an estimated $1.73M.
  • Laurion Capital Management first reported a position in DexCom in Q2 2015 and held it in 9 quarters.
  • Laurion Capital Management's DexCom position peaked at $5.39M in Q2 2015.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Laurion Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.